, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

Mkt Outperform
down 64.27 %

Ariad Pharmaceuticals, Inc. (ARIA) upgraded to Mkt Outperform with price target $26 by Rodman & Renshaw

Posted on: Tuesday,  Jul 31, 2012  10:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 07/31/2012, when the stock price was $19.54.
Since then, Ariad Pharmaceuticals, Inc. has lost 64.28% as of 01/19/2016's recent price of $6.98.
If you would have followed this Rodman & Renshaw's recommendation on ARIA, you would have lost 64.27% of your investment in 1267 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/31/2012 10:25 AM Buy
19.54 26.00
as of 12/31/2012
1 Week down  -5.84 %
1 Month down  -14.22 %
3 Months down  -20.77 %
1 YTD down  -1.84 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/27/2011 8:25 AM Hold
11.79 18.00
10/14/2011 8:25 AM Buy
10.19 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy